Elevance Health, Inc. (ELV)

NYSE · Healthcare Plans

398.40
+8.16 (+2.09%)
Updated Aug 18, 5:22 PM ET
AI Rating
Hold
Overall Score
54
Trend
32
Momentum
71
Risk
64

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 19, 2026 120 sessions Aug 14, 2026

AI Analysis

Elevance Health, Inc. is trading at $398.40, up 2.09% on the session. The 50 day average sits at $397.00 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 55.2, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $387.23 with resistance near $408.00, so that band frames the current range. Average daily movement is roughly $11.75, or about 3.0% of the share price, which is what any stop placement has to allow for. The overall health score of 54 out of 100 combines a trend score of 32, momentum of 71 and a risk score of 64.

Technical indicators

RSI (14)
55.2
strong
MACD
0.604
bullish crossover
SMA 20
385.77
SMA 50
397.00
SMA 200
--
unknown
ATR (14)
11.75
avg daily range
Support
387.23
Resistance
408.00
Volume vs 20d
0.52x
below average
Volatility
43.4%
annualised
1 month
-5.85%
3 months
+4.86%

About Elevance Health, Inc.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.